Duato Joaquin's most recent trade in Johnson & Johnson was a trade of 130,852 Common Stock done . Disclosure was reported to the exchange on March 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Mar 2025 | 130,852 | 130,852 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Mar 2025 | 130,852 | 275,967 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 219,020 | 219,020 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 13,513 | 13,513 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 19,282 | 0 | - | - | Performance Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 19,282 | 415,205 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.71 per share. | 13 Feb 2025 | 8,386 | 406,819 (0%) | 0% | 156.7 | 1,314,170 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 5,053 | 0 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 5,053 | 396,041 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,682 | 7,364 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,682 | 397,525 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,470 | 3,469 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,470 | 392,498 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.71 per share. | 13 Feb 2025 | 2,198 | 393,843 (0%) | 0% | 156.7 | 344,449 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.15 per share. | 13 Feb 2025 | 1,602 | 395,923 (0%) | 0% | 156.1 | 250,152 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 155.26 per share. | 13 Feb 2025 | 1,510 | 390,988 (0%) | 0% | 155.3 | 234,443 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 19,282 | 19,282 | - | - | Performance Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 126,369 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.06 per share. | 07 Feb 2025 | 126,369 | 489,671 (0%) | 0% | 100.1 | 12,644,482 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 153.12 per share. | 07 Feb 2025 | 100,643 | 389,028 (0%) | 0% | 153.1 | 15,410,456 | Common Stock |
| Johnson & Johnson | Duato Joaquin | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 177,816 | 177,816 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 11,046 | 11,046 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 3,470 | 364,809 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 3,470 | 6,939 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.85 per share. | 13 Feb 2024 | 1,507 | 363,302 (0%) | 0% | 157.9 | 237,880 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 31,351 | 0 | - | - | Performance Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 31,351 | 371,972 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.40 per share. | 12 Feb 2024 | 15,900 | 361,339 (0%) | 0% | 157.4 | 2,502,660 | Common Stock |
| Johnson & Johnson | Duato Joaquin | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 5,267 | 377,239 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Duato Joaquin | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 130,969 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Duato Joaquin | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 90.44 per share. | 09 Feb 2024 | 130,969 | 439,283 (0%) | 0% | 90.4 | 11,844,836 | Common Stock |
| Johnson & Johnson | Duato Joaquin | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.76 per share. | 09 Feb 2024 | 98,662 | 340,621 (0%) | 0% | 156.8 | 15,466,255 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 5,225 | 310,583 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 5,225 | 0 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.33 per share. | 08 Feb 2024 | 2,269 | 308,314 (0%) | 0% | 156.3 | 354,713 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Aug 2023 | 11,035 | 305,358 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 172,250 | 172,250 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 31,319 | 329,992 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.01 per share. | 13 Feb 2023 | 13,599 | 316,393 (0%) | 0% | 162.0 | 2,203,174 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 10,409 | 10,409 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 5,220 | 0 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 5,220 | 300,940 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.08 per share. | 10 Feb 2023 | 2,267 | 298,673 (0%) | 0% | 162.1 | 367,435 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 148,538 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.54 per share. | 17 Jan 2023 | 148,538 | 394,515 (0%) | 0% | 72.5 | 10,774,947 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.43 per share. | 17 Jan 2023 | 98,795 | 295,720 (0%) | 0% | 173.4 | 17,134,017 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 99,811 | 99,811 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joaquin Duato | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 29,714 | 2,832 | - | - | Performance Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 29,714 | 258,879 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.89 per share. | 14 Feb 2022 | 12,902 | 245,977 (0%) | 0% | 165.9 | 2,140,313 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 5,424 | 0 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 5,424 | 231,521 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 5,053 | 5,053 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joaquin Duato | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 168.85 per share. | 14 Feb 2022 | 2,356 | 229,165 (0%) | 0% | 168.9 | 397,811 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 84,423 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joaquin Duato | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.37 per share. | 14 Jan 2022 | 84,423 | 280,475 (0%) | 0% | 65.4 | 5,518,732 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 167.84 per share. | 14 Jan 2022 | 54,378 | 226,097 (0%) | 0% | 167.8 | 9,126,804 | Common Stock |
| Hess | Joaquin Duato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2021 | 2,332 | 6,392 (0%) | 0% | 0 | Common Stock, $1.00 par value | |
| Johnson & Johnson | Joaquin Duato | Vice Chair, Exec Committee | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 27,738 | 0 | - | - | Performance Share Units | |
| Johnson & Johnson | Joaquin Duato | Vice Chair, Exec Committee | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 27,738 | 204,207 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Vice Chair, Exec Committee | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.55 per share. | 12 Feb 2021 | 11,931 | 196,052 (0%) | 0% | 165.5 | 1,975,177 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Vice Chair, Exec Committee | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 5,283 | 0 | - | - | Restricted Share Units | |
| Johnson & Johnson | Joaquin Duato | Vice Chair, Exec Committee | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 5,283 | 209,490 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Joaquin Duato | Vice Chair, Exec Committee | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.55 per share. | 12 Feb 2021 | 1,507 | 207,983 (0%) | 0% | 165.6 | 249,484 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Vice Chair, Exec Committee | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 114,776 | 114,776 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joaquin Duato | Vice Chair, Exec Committee | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 27,738 | 27,738 | - | - | Performance Share Units | |
| Johnson & Johnson | Joaquin Duato | Vice Chair, Exec Committee | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 5,225 | 5,225 | - | - | Restricted Share Units |